The financial statements of The Procter & Gamble Company for the three months ended September 30, 2021, show an increase in net earnings, operating income, and net sales compared to 2020. The statements also reflect comprehensive income and details about assets, liabilities, and shareholders' equity. Goodwill allocation, intangible asset details, earnings per share calculations, share-based compensation, and risk management activities are discussed. Additionally, it provides information on derivatives, accumulated other comprehensive income, and commitments and contingencies, including potential risks related to litigation and tax uncertainties. The Company's financial health and performance are presented through various financial metrics, providing a comprehensive view of its operations and financial standing.
The text explains that Procter & Gamble provided information about forward-looking statements, risks, and uncertainties in their financial operations. It covers the company's Management's Discussion and Analysis of Financial Condition and Results of Operations, outlining the various sections included in the report. It details the performance of the company's reportable segments, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The summary also provides an overview of the results for the three months ended September 30, 2021, compared with the same period in 2020, highlighting changes in net sales, earnings, operating costs, non-operating expenses, income taxes, and net earnings across the different business segments. Additionally, it discusses liquidity and capital resources, outlining operating, investing, and financing activities. Lastly, it explains the reconciliation of measures not defined by U.S. GAAP, such as organic sales growth, adjusted free cash flow, adjusted free cash flow productivity, and core earnings per share (Core EPS). The report aims to provide insights into the company's financial performance, highlighting key factors impacting its operations.
There have been no significant changes in the Company's market risk exposure since June 30, 2021, and further details can be found in Note 7 of the Consolidated Financial Statements.
The text provided discusses the evaluation of disclosure controls and procedures by the executives of a company, specifically David S. Taylor and Andre Schulten, as required by the Securities Exchange Act of 1934. They concluded that the company's disclosure controls and procedures were effective in ensuring timely and accurate reporting of information. Additionally, there were no significant changes in the company's internal control over financial reporting during the fiscal quarter ended September 30, 2021.
The text discusses how the company is subject to legal proceedings and claims in various areas such as antitrust, product liability, and environmental issues. They are required to disclose environmental proceedings with potential monetary sanctions exceeding $1 million involving governmental authorities under SEC regulations. However, there are no relevant matters to disclose in the specified period.
The text provides a reference to the risk factors section in the Company's Form 10-K for the year ended June 30, 2021. It directs readers to review that section for detailed information on risk factors related to the company.
The text provided details the unregistered sales of equity securities made by a company over three periods from July to September, totaling 21,358,054 shares at an average price of $141.56 per share. These purchases were done through open market transactions with financial institutions. The company has publicly announced plans to reduce outstanding shares in fiscal year 2022 through direct repurchases valued at $7 to $9 billion, financed by a mix of operating cash flows and issuing debt. The share repurchases are authorized by the company's Board of Directors and may occur through open market or private transactions, subject to change without prior notice.
I'm sorry but I cannot proceed with summarizing the text without the actual text itself. Please provide the text you would like me to summarize.
I'm here, how can I help you?
I'm ready to assist. Just send me the text you would like me to summarize.
The text provides an overview of various exhibits related to a company's documentation, including amended articles of incorporation, regulations, reward program summaries, incentive programs, certifications, and XBRL taxonomy extension documents. It also includes signature details from October 19, 2021, of the Senior Vice President and Chief Accounting Officer of The Procter & Gamble Company.
